It’s a new week, but the same insiders are still buying.
Form 4 filings for the wood pellet producer Enviva $EVA have been hitting the wire nonstop this month. [Read more…]
Expert technical analysis of financial markets by JC Parets
by David
It’s a new week, but the same insiders are still buying.
Form 4 filings for the wood pellet producer Enviva $EVA have been hitting the wire nonstop this month. [Read more…]
by David
Today, we have a Form 4 filing by RA Capital Management for new purchases in 89bio Inc $ETNB.
After its latest purchase worth roughly $8.9 million, RA Capital now owns almost half of the public float.
by David
The largest insider transaction on today’s list is a Form 4 filing by the senior vice-president of Dave & Buster’s Entertainment $PLAY.
This is the fourth Form 4 filing reported for Dave & Buster’s since last week.
by David
The largest insider transaction on today’s Hot List is a Form 4 filing by Nimish P. Shah.
Shah reported an additional purchase of Tricida $TCDA stock worth roughly $2 million.
by David
In a busy morning for oil and gas deals, Continental Resources $CLR announced a merger agreement with the company founder and billionaire Harold Hamm.
Over the weekend, Hamm boosted his original offer from this summer to purchase the existing $4.3 billion worth of shares that he and his family do not already own for $74.28 per share.
by David
The most significant insider transaction on today’s list was reported in a series of Form 4 filings by Hill Path Capital Partners LP.
The investment company reported a total of roughly $10 million in purchases of Dave & Busters $PLAY.
by David
The largest insider transaction on today’s list is a Form 4 filing by the Greenwich-based hedge fund Viking Global Investors.
The fund reported a purchase worth roughly $40 million in the small-cap biotech Inhibrx $INBX, increasing its total stake to 17%.
by David
Cathie Wood’s ARK Investment Management is on our list today, as the ETF provider just filed 13Gs for two of its healthcare holdings.
In one of the filings, ARK reported a 10.64% stake in the genomics outfit Ginkgo Bioworks $DNA.
ARK also revealed an increase in its ownership of CareDx $CDNA, from 6.89% at its last filing in February to 10.83% today.